Please cite this article in press M.S Manasa et al., A Review On Exploring 3D Printing Techniques For Solid Dosage Forms, Indo Am. J. P. Sci, 2024; 11 (01).

[1]. ISO/ASTM 52900:2015(en). Additive manufacturing – general Principles-Terminology. 2018 March 26.
Available from https ://www.iso.org/obp/ui/#iso:std:iso-astm:52900:ed 1:v1:en.
[2]. Murr Lawrence E. Frontiers of 3D printing /additive manufacturing: from human organs to aircraft fabrication. JMater Sci Technol 2016.
[3]. Kumar M. Advances in welding technologies for process development. (No Title) 2019:77.
https://doi.org/10.1201/ 9781351234825.
[4]. Horn Timothy J, Ola LA Harrysson. Overview of current additive manufacturing technologies and selected applications. Sci Pro 2012.
[5]. Lee Hyub, et al. Lasers in additive manufacturing: A review. Int J Prec Eng Manufact Green Technol 2017. technology: A mini-review. J Drug Deliv SciTechnol 2018.
[6]. Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Teung P,Cima MJ. Oral dosage forms fabricated by Threedimensional Printing. J Contr Release 2000.
[7]. Cui M, Pan H, Fang D, Qiao S, Wang S, Pan W. Fabrication of high drug loading levetiracetam tablets using semisolid extrusion 3D printing. J Drug Deliv Sci Technol 2020.
[8]. Bartolo, Jorge Paulo, editors. Stereo lithography: materials, processes and applications. Springer Science & Business Media; 2011.
[9]. Konta Andrea Alice, García-Pina Marta, Serrano Dolores R. Personalised 3D printed medicines: which techniques and polymers are more successful? Bioengineering 2017.
[10]. Chen P, Luo H, Huang S, Liu J, Lin M, Yang F…, Chen Y. Preparation of high-drug-loaded clarithromycin gastricfloating sustained-release tablets using 3D printing. AAPS Pharm Sci Tech 2021;22: 1e10.
https://doi.org/10.1208/s12249-021-01994-z.
[11]. Liu, Z.; Wang, Y.; Wu, B.; Cui, C.; Guo, Y.; Yan, C. A critical review of fused deposition modeling 3D printing technology in manufacturing polylactic acid parts. Int. J. Adv. Manuf. Technol. 2019.
[12]. Kotomin, S.V.; Kramarev, D.V.; Obidin, I.M.; Polunin, S.V. Influence of 3D Printing Conditions of Polyethylene Terephthalate Glycol on the Mechanical Properties of Products Based on It. Polym. Sci. Ser. A 2022.
[13]. Schubert, C.; Van Langeveld, M.C.; Donoso, L.A. Innovations in 3D printing: A 3overview from optics to organs.Br. J. Ophthalmol. 2014.
[14]. Mahmood, M.A.; Popescu, A.C.; Mihailescu, I.N. Metal Matrix Composites Synthesized by Laser-Melting Deposition: A Review. Material 2017.
[15]. Khatri, P.; Shah, M.K.; Vora, N. Formulation strategies for solid oral dosage form using 3D printing technology: A mini-review. J. Drug Deliv. Sci. Technol. 2018.
[16]. Mertz, L. New World of 3-D Printing Offers “Completely New Ways of Thinking”: Q&A with Author, Engineer, and 3-D Printing Expert Hod Lipson. IEEE Pulse 2013.
[17]. Marzuka SK, Kulsum JU., 3D Printing, a new avenue in pharmaceuticals, World Journal of Pharmaceutical Research, 2016.
[18]. Davoudigejad A, Diaz Perez LC, Quagliotti D, et al. (2018) Geometric and feature size design effect on vat photo polymerization micro additively manufactured surface features. Proceedings – 2018 ASPE and euspen Summer Topical Meeting: Advancing Precision in Additive Manufacturing (July): 55–59.
[19]. Shahrubudin N, Lee TC, Ramlan R. An overview on 3D printing technology: Technological, materials, and applications. Procedia Manuf [Internet]. 2019.
[20]. Basit AW, Gaisford S, editors. 3D Printing of Pharmaceuticals [Internet]. Cham: Springer International Publishing; 2018. (AAPS Advances in the Pharmaceutical Sciences Series; vol. 31). Available from:
http://link.springer.com/10.1007/978-3-319-90755-0
[21]. Zhang Y, Jarosinski W, Jung Y-G, Zhang J. Additive manufacturing processes and equipment. In: Additive Manufacturing[Internet].Elsevier;2018.p.39–51Available from https://linkinghub.elsevier.com/retrieve/pii/B9780128121559000025
[22]. Molitch-Hou M. Overview of additive manufacturing process. In: Additive Manufacturing. Elsevier; 2018. p. 1-38. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128121559000013
[23]. E. Lepowsky and S. Tasoglu, “3D printing for drug manufacturing: A perspective on the future of
pharmaceuticals,” Int. J. Bioprinting, vol. 4, no. 1, p. 119, 2018.
[24]. W. Jamroz, J. Koterbicka, M. Kurek, A. Czech, and R. Jachowicz, “Application of 3D printing in pharmaceutical technology,” Farm. Pol., vol. 73, pp. 542–548.
[25]. S. E. Moulton and G. G. Wallace, “3-dimensional (3D) fabricated polymer based drug delivery systems,” J.Control. Release, vol. 193, pp. 27–34, 2014.
[26]. K. J. Lee et al., “Evaluation of Critical Formulation Factors in the Development of a Rapidly Dispersing Captopril Oral Dosage Form,” Drug Dev. Ind. Pharm., vol. 29, no. 9, pp. 967–979, 2003.
[27]. F. Fina, A. Goyanes, S. Gaisford, and A. W. Basit, “Selective laser sintering (SLS) 3D printing of medicines,” Int. J. Pharm., vol. 529, no. 1–2, pp. 285–293, 2017.
[28]. F. Fina, C. M. Madla, A. Goyanes, J. Zhang, S. Gaisford, and A. W. Basit, “Fabricating 3D printed orally disintegrating print lets using selective laser sintering,” Int. J. Pharm., vol. 541, no. 1–2, pp. 101–107, 2018.
[29]. S. A. Khaled, J. C. Burley, M. R. Alexander, J. Yang, and C. J. Roberts, “3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles,” J. Control. Release, vol. 217, pp. 308– 314, 2015.
[30]. W. Jamróz et al., “3D printed or dispersible films with Aripiprazole,” Int. J. Pharm., vol. 533, no. 2, pp. 413– 420, 2017.
[31]. A. Goyanes et al., “Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing,” Int. J.Pharm., 2015.
[32]. C. I. Gioumouxouzis et al., “Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients,” Eur. J. Pharm. Sci., vol. 143, 2020.
[33]. B. Arafat et al., “Tablet fragmentation without a disintegrate: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets,” Eur. J. Pharm. Sci., vol. 118, pp. 191–199, 2018.
[34]. C. C. Wang et al., “Development of near zero-order release dosage forms using three-dimensional printing (3DPTM) technology,” Drug Dev. Ind. Pharm., vol. 32, no. 3, pp. 367–376, 2006.
[35]. C. P. P. Pere et al., “3D printed micro needles for insulin skin delivery,” Int. J. Pharm., vol. 544, no. 2, pp. 425– 432, Jun. 2018.
[36]. A. Melocchi, F. Parietti, A. Maroni, A. Foppoli, A. Gazzaniga, and L. Zema, “Hot melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling,” Int. J. Pharm., vol. 509, no. 1–2, pp. 255–263, 2016.
[37]. D. K. Tan, M. Maniruzzaman, and A. Nokhodchi, “Advanced pharmaceutical applications of hot-melt extrusion coupled with fused deposition modelling (FDM) 3D printing for personalized drug delivery,” Pharmaceutics, vol,10, no. 4, 2018.
[38]. B. Redwood, F. Schffer, B. Garret, and B. Igor, The 3D printing handbook: technologies, design and applications, no. c. Amsterdam, The Netherlands: 3D Hubs, 2017.
[39]. S. Mohanty et al., “Fabrication of scalable and structured tissue engineering scaffolds using water dissolvable sacrificial 3D printed moulds,” Mater. Sci. Eng. C, vol. 55, pp. 569–578, 2015.
[40]. L. Zema, A. Melocchi, A. Maroni, and A. Gazzaniga, “Three-Dimensional Printing of Medicinal Products and the Challenge of Personalized Therapy,” J. Pharm. Sci., vol. 106, no. 7, pp. 1697–1705, Mar. 2017.
[41]. A. Goyanes, A. B. M. M. Buanz, A. W. Basit, and S. Gaisford, “Fused-filament 3D printing (3DP) for fabrication of tablets,” Int. J. Pharm., vol. 476, no. 1, pp. 88–92, 2014.
[42]. E. Prasad et al., “Development of a hot-melt extrusion (HME) process to produce drug loaded AffinisolTM 15LV filaments for fused filament fabrication (FFF) 3D printing,” Addit. Manuf., vol. 29, p. 100776, Oct. 2019.
[43]. M. Alhijjaj, P. Belton, and S. Qi, “An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing,” Eur. J. Pharm. Biopharm., vol. 108, pp. 111–125, 2016.
[44]. A. Goyanes, A. B. M. Buanz, G. B. Hatton, S. Gaisford, and A. W. Basit, “3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets,” Eur. J. Pharm. Biopharm., vol. 89, no. Supplement C, pp. 157–162, 2015.
[45]. A. Goyanes, A. B. M. Buanz, A. W. Basit, and S. Gaisford, “Fused-filament 3D printing (3DP) for fabrication of tablets,” Int. J. Pharm., vol. 476, no. 1, pp. 88–92, 2014.
[46]. W. E. Katstra, R. D. Palazzolo, C. W. Rowe, B. Giritlioglu, P. Teung, and M. J. Cima, Oral dosage forms fabricated by 3Dimensional Printing,” J. Control. Release, vol. 66, pp. 1–9, 2000.
[47]. A. Goyanes, M. Scarpa, M. Kamlow, S. Gaisford, A. W. Basit, and M. Orlu, “Patient acceptability of 3D printed medicines,” Int. J. Pharm., vol. 530, no. 1–2, pp. 71–78, 2017.
[48]. A. Goyanes, M. Scarpa, M. Kamlow, S. Gaisford, A. W. Basit, and M. Orlu, “Patient acceptability of 3D printed medicines,” Int. J. Pharm., vol. 530, no. 1–2, pp. 71–78, 2017.
[49]. F. Liu, A. Ghaffur, J. Bains, and S. Hamdy, “Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study,” Int. J. Pharm., vol. 512, no. 2, pp. 374– 381, 2016.
[50]. A. Melocchi, F. Parietti, G. Loreti, A. Maroni, A. Gazzaniga, and L. Zema, “3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs,” J. Drug Deliv. Sci.Technol.
[51]. I. Pilipenko et al., “pH-Sensitive Chitosan–Heparin Nanoparticles for Effective Delivery of Genetic Drugs into Epithelial Cells,” Pharmaceutics, Jul. 2019.
[52]. M. A. Luzuriaga, D. R. Berry, J. C. Reagan, R. A. Smaldone, and J. J. Gassensmith, “Biodegradable 3D printed polymer micro needles for transdermal drug delivery,” Lab Chip, 2018.
[53]. M. Nadgorny, Z. Xiao, C. Chen, and L. A. Connal, “Three-Dimensional Printing of pH-Responsive and Functional Polymers on an Affordable Desktop Printer,” ACS Appl. Mater. Interfaces, 2016.
[54] S. Dutta and D. Cohn, “Temperature and pH responsive 3D printed scaffolds,” J. Mater. Chem. B, 2017.
[55]. Chen H, Fuhlbrigge TA, Zhang G. Application of fused deposition modelling in controlled drug delivery devices. Assembly automation, 2007.